metoclopramide has been researched along with Cancer of Pancreas in 8 studies
Metoclopramide: A dopamine D2 antagonist that is used as an antiemetic.
metoclopramide : A member of the class of benzamides resulting from the formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with the primary amino group of N,N-diethylethane-1,2-diamine.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The aim of the study was to evaluate the role of ramosetron for the prevention of chemoradiotherapy-induced nausea and vomiting (CRINV) in patients receiving upper abdominal irradiation with concurrent 5-fluorouracil chemotherapy." | 7.75 | Ramosetron for the prevention of nausea and vomiting during 5-fluorouracil-based chemoradiotherapy for pancreatico-biliary cancer. ( Bang, YJ; Chie, EK; Ha, SW; Im, SA; Jang, JY; Kim, K; Kim, SW; Kim, TY; Oh, DY, 2009) |
| "A patient who was given metoclopramide for vomiting and diarrhoea developed circulatory collapse with his blood pressure dropping to 50/20 mm Hg." | 7.75 | Circulatory collapse in a patient with gastrinoma after metoclopramide administration. ( Chan, AY; Chan, KW; Ching, CK; Lam, AW; Lau, KK; Lee, HH; Li, SM; Lo, J; Lok, CM; Luk, WF; Mak, CM, 2009) |
| "The aim of the study was to evaluate the role of ramosetron for the prevention of chemoradiotherapy-induced nausea and vomiting (CRINV) in patients receiving upper abdominal irradiation with concurrent 5-fluorouracil chemotherapy." | 3.75 | Ramosetron for the prevention of nausea and vomiting during 5-fluorouracil-based chemoradiotherapy for pancreatico-biliary cancer. ( Bang, YJ; Chie, EK; Ha, SW; Im, SA; Jang, JY; Kim, K; Kim, SW; Kim, TY; Oh, DY, 2009) |
| "A patient who was given metoclopramide for vomiting and diarrhoea developed circulatory collapse with his blood pressure dropping to 50/20 mm Hg." | 3.75 | Circulatory collapse in a patient with gastrinoma after metoclopramide administration. ( Chan, AY; Chan, KW; Ching, CK; Lam, AW; Lau, KK; Lee, HH; Li, SM; Lo, J; Lok, CM; Luk, WF; Mak, CM, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (37.50) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tandon, M | 1 |
| Coudriet, GM | 1 |
| Criscimanna, A | 1 |
| Socorro, M | 1 |
| Eliliwi, M | 1 |
| Singhi, AD | 1 |
| Cruz-Monserrate, Z | 1 |
| Bailey, P | 1 |
| Lotze, MT | 1 |
| Zeh, H | 1 |
| Hu, J | 1 |
| Goffin, V | 1 |
| Gittes, GK | 1 |
| Biankin, AV | 1 |
| Esni, F | 1 |
| Silvestris, N | 1 |
| Brunetti, AE | 1 |
| Russano, M | 1 |
| Nardulli, P | 1 |
| Zhang, XF | 1 |
| Yin, GZ | 1 |
| Liu, QG | 1 |
| Liu, XM | 1 |
| Wang, B | 1 |
| Yu, L | 1 |
| Liu, SN | 1 |
| Cui, HY | 1 |
| Lv, Y | 1 |
| Kim, K | 1 |
| Chie, EK | 1 |
| Jang, JY | 1 |
| Kim, SW | 1 |
| Oh, DY | 1 |
| Im, SA | 1 |
| Kim, TY | 1 |
| Bang, YJ | 1 |
| Ha, SW | 1 |
| Lau, KK | 1 |
| Chan, KW | 1 |
| Lok, CM | 1 |
| Lam, AW | 1 |
| Lee, HH | 1 |
| Luk, WF | 1 |
| Mak, CM | 1 |
| Ching, CK | 1 |
| Lo, J | 1 |
| Li, SM | 1 |
| Chan, AY | 1 |
| Long, RG | 1 |
| Bryant, MG | 1 |
| Yuille, PM | 1 |
| Polak, JM | 1 |
| Bloom, SR | 1 |
| Tochner, ZA | 1 |
| Kinsella, TJ | 1 |
| Glatstein, E | 1 |
| Malfertheiner, P | 1 |
| Büchler, M | 1 |
| Müller, A | 1 |
| Ditschuneit, H | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Phase III Prospective Randomized Trial Comparing Ramosetron Versus Ondansetron for Radiotherapy Induced Nausea and Vomiting in the Treatment of Gastrointestinal Cancer[NCT00971399] | Phase 3 | 172 participants (Anticipated) | Interventional | 2009-09-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for metoclopramide and Cancer of Pancreas
| Article | Year |
|---|---|
Optimal control of nausea and vomiting with a three-drug antiemetic regimen with aprepitant in metastatic pancreatic cancer patients treated with first-line modified FOLFIRINOX.
Topics: Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Aprepitant; Benztropine; Camptoth | 2013 |
7 other studies available for metoclopramide and Cancer of Pancreas
| Article | Year |
|---|---|
Prolactin Promotes Fibrosis and Pancreatic Cancer Progression.
Topics: Animals; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Collagen; Disease Progression; Epithelium; | 2019 |
Does Braun enteroenterostomy reduce delayed gastric emptying after pancreaticoduodenectomy?
Topics: Abdominal Abscess; Acupuncture; Anastomotic Leak; Antiemetics; Domperidone; Enterostomy; Erythromyci | 2014 |
Ramosetron for the prevention of nausea and vomiting during 5-fluorouracil-based chemoradiotherapy for pancreatico-biliary cancer.
Topics: Adult; Aged; Antiemetics; Benzimidazoles; Biliary Tract Neoplasms; Chemotherapy, Adjuvant; Female; F | 2009 |
Circulatory collapse in a patient with gastrinoma after metoclopramide administration.
Topics: Adolescent; Dopamine Antagonists; Gastrinoma; Humans; Male; Metoclopramide; Nausea; Pancreatic Neopl | 2009 |
Mixed pancreatic apudoma with symptoms of excess vasoactive intestinal polypeptide and insulin: improvement of diarrhoea with metoclopramide.
Topics: Apudoma; Diarrhea; Female; Gastrointestinal Hormones; Humans; Insulin; Insulin Secretion; Metoclopra | 1981 |
Hepatic irradiation in the management of metastatic hormone-secreting tumors.
Topics: Adenoma, Islet Cell; Adult; Diarrhea; Female; Hemangiopericytoma; Humans; Laparotomy; Liver Neoplasm | 1985 |
[The fluorescein dilaurate serum test following metoclopramide and secretin stimulation for evaluating pancreatic function. Contribution to the diagnosis of chronic pancreatitis].
Topics: Chronic Disease; Diagnosis, Differential; Female; Fluoresceins; Humans; Male; Metoclopramide; Middle | 1987 |